
This zzso open label follow-up study had three zzso 1) To observe the course of illness in zzso Disorder patients receiving long-term versus zzso zzso treatment, 2) To compare the zzso rates and zzso profile after long-term zzso treatment between patients with zzso Disorder and zzso Disorder with zzso 3) To observe zzso zzso over a 24 month zzso 

143 patients with panic disorder zzso with or without zzso successfully finished a short-term zzso 12 week) trial of zzso zzso All patients then continued to receive zzso maintenance therapy for a total of 12 zzso At the end of this period, 72 of the patients chose to zzso zzso zzso and agreed to be monitored throughout a one year zzso follow-up zzso The remaining 71 patients continued on zzso for an additional 12 months and then were zzso as in the first group, for another year while zzso The primary limitation of our study is that the zzso of patients receiving 12 versus 24 months of maintenance zzso therapy were selected according to individual patient preference and therefore were not assigned in a zzso zzso 

Only 21 of 143 patients zzso relapsed during the one year medication zzso follow-up zzso There were no significant differences in zzso rates between the patients who received zzso (up to 12 zzso zzso and those who chose the long-term course (24 month zzso zzso 43 patients zzso reported sexual zzso The patients exhibited an average weight gain of zzso zzso All patients who eventually relapsed demonstrated significantly greater weight increase zzso zzso during the treatment zzso 

The extension of zzso maintenance treatment from 12 to 24 months did not seem to further decrease the risk of zzso after medication zzso zzso month zzso treatment is accompanied by sexual side effects and weight gain similar to those observed in twelve month zzso 

